Paracetamol (acetaminophen) poisoning

https://doi.org/10.1016/0163-7258(93)90023-7Get rights and content

Abstract

Paracetamol poisoning caused by intentional overdose remains a common cause of morbidity. In this article the mechanism of toxicity and the clinical effects and treatment of poisoning, including specific antidotal therapy, are reviewed. Areas for further research directed at reducing morbidity and mortality from paracetamol poisoning are considered.

References (251)

  • M.F. Dixon

    Paracetamol hepatoxicity

    Lancet

    (1976)
  • A.P. Douglas et al.

    Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning

    Lancet

    (1976)
  • N.R. Farid et al.

    Haemodialysis in paracetamol self-poisoning

    Lancet

    (1972)
  • R.E. Ferner et al.

    Acetylcysteine in paracetamol poisoning

    Lancet

    (1990)
  • R. Grafström et al.

    Paracetamol metabolism in the isolated perfused rat liver with further metabolism of a biliary paracetamol conjugate by the small intestine

    Biochem. Pharmac.

    (1979)
  • P.M. Harrison et al.

    Improved outcome of paracetamol-induced fulminant failure by late administration of N-acetyl cysteine

    Lancet

    (1990)
  • J.A. Hinson et al.

    Mechanism of paracetamol toxicity

    Lancet

    (1990)
  • J.A. Holme et al.

    Cytotoxic effects of N-acetyl-p-benzo-quinonimine, a common arylating intermediate of paracetamol and N-hydroxyparacetamol

    Biochem. Pharmac.

    (1984)
  • O. James et al.

    Liver damage after paracetamol overdose: comparison of liver function tests, fasting serum bile acids and liver histology

    Lancet

    (1975)
  • E. Albano et al.

    Mechanisms of N-acetyl-para-benzoquinone imine cytotoxicity

    Molec. Pharmac.

    (1985)
  • J. Ambre et al.

    Liver toxicity after acetaminophen ingestion. Inadequacy of the dose estimate as an index of risk

    J. Am. Med. Ass.

    (1977)
  • N.J. Baeg et al.

    Long-term sequelae of acetaminophen-associated FHF: relevance of early histology

    Am. J. Gastroenterol.

    (1988)
  • J.D. Barker et al.

    Chronic excessive acetaminophen use and liver damage

    Ann. intern. Med.

    (1977)
  • D.N. Bateman et al.

    Adverse reactions to N-acetyl cysteine

    Hum. Toxic.

    (1984)
  • G.J. Beckett et al.

    Plasma glutathione S-transferase and F protein as markers of paracetamol (acetaminophen)-induced liver damage

    Clin. Chem.

    (1989)
  • M.S. Benedetti et al.

    Prevention of paracetamol-induced liver damage in mice with glutathione

    J. Pharm. Pharmac.

    (1975)
  • G.D. Benson

    Acetaminophen in chronic liver disease

    Clin. Pharmac. Ther.

    (1983)
  • H. Bismuth et al.

    Emergency liver transplant for fulminant hepatitis

    Ann. Intern. Med.

    (1987)
  • M. Black et al.

    Acetaminophen, alcohol and cytochrome P450

    Ann. Intern. Med.

    (1986)
  • M. Black et al.

    Late presentation of acetaminophen hepatotoxicity

    Dig. Dis. Sci.

    (1982)
  • L. Bonanomi et al.

    Toxicological, pharmacokinetic and metabolic studies on acetylcysteine

    Eur. Resp. Dis.

    (1980)
  • M.F. Bonfiglio et al.

    Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities

    Ann. Pharmacother.

    (1992)
  • L. Borgström et al.

    Pharmacokinetics of N-acetylcysteine in man

    Eur. J. Clin. Pharmac.

    (1986)
  • E.M. Boyd et al.

    Liver necrosis from paracetamol

    Br. J. Pharmac.

    (1966)
  • T.D. Boyer et al.

    Acetaminophen induced hepatic necrosis and renal failure

    J. Am. Med. Ass.

    (1971)
  • G. Bray et al.

    N-acetyl-cysteine in the treatment of acetaminophen overdose

    New Engl. J. Med.

    (1989)
  • G.P. Bray et al.

    Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure

    Hum. Exp. Toxic.

    (1992)
  • M.K. Bruno et al.

    Antidotal effectiveness of NAC in reversing acetaminophen-induced hepatotoxicity: enhancement of the proteolysis of arylated proteins

    Biochem. Pharmac.

    (1988)
  • J.M. Burgunder et al.

    Effect of N-acetyl-cysteine on plasma cysteine and glutathione following paracetamol administration

    Eur. J. Clin. Pharmac.

    (1989)
  • A.J. Byer et al.

    Acetaminophen overdose in the third trimester of pregnancy

    J. Am. Med. Ass.

    (1982)
  • F.J. Cairns et al.

    Death from drugs and poisons

    NZ Med. J.

    (1983)
  • J. Canalese et al.

    Factors contributing to mortality in paracetamol-induced hepatic failure

    Br. Med. J.

    (1981)
  • S. Chiu et al.

    Experimental acetaminophen-induced hepatic necrosis: biochemical and electron microscopic study of cysteamine protection

    Lab. Invest.

    (1978)
  • R. Clark et al.

    Hepatic damage and death from overdose of paracetamol

    Lancet

    (1973)
  • J.A. Clements et al.

    The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man

    Br. J. Clin. Pharmac.

    (1984)
  • I. Cobden et al.

    Paracetamol-induced acute renal failure in the absence of fulminant liver damage

    Br. Med. J.

    (1982)
  • G.B. Corocan et al.

    Evidence that acetaminophen and N-hydroxy-acetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine

    Molec. Pharmac.

    (1980)
  • R.A. Coward

    Paracetamol-induced acute pancreatitis

    Br. Med. J.

    (1977)
  • D.C. Dahlin et al.

    N-acetyl-p-benzoquinonimine: a cytochrome P450 mediated oxidation product of acetaminophen

  • A. Davenport et al.

    Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma

    Nephron

    (1988)
  • Cited by (183)

    • Effects of blue-light irradiation during dental treatment

      2018, Japanese Dental Science Review
      Citation Excerpt :

      N-acetyl-l-cysteine (NAC) has been shown to scavenge oxidants directly and to increase intracellular glutathione levels, which is of paramount importance for protecting organelles from the oxidative stress associated with the ROS produced during coupled mitochondrial electron transport and oxidative phosphorylation [76–78]. Furthermore, NAC has been used clinically for the treatment of many diseases for decades [79]. In recent years, it was suggested that NAC might abrogate inflammation- or oxidative stress-induced hyperfunction in oral mucosal cells [80].

    View all citing articles on Scopus
    View full text